MICHAEL GIOVANNIELLO: Open Payments
NPI 1285604462 · SANDY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$534 in 25 payments from 9 companies in 2025. Trend: 2023 $857 · 2024 $422 · 2025 $534
Food & beverage: $534
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $314 |
| Boston Scientific Corporation | 2 | $38 |
| Medtronic, Inc. | 2 | $37 |
| Solventum Corporation | 1 | $34 |
| Procept Biorobotics Corporation | 1 | $33 |
| INTERNATIONAL REHABILITATIVE SCIENCES, INC | 1 | $27 |
| Collegium Pharmaceutical, Inc. | 1 | $21 |
| SI-BONE, INC. | 1 | $16 |
| Azurity Pharmaceuticals, Inc. | 1 | $14 |
Products named: QULIPTA, BOTOX, PREVENA, AQUABEAM ROBOTIC SYSTEM, RS 4i Plus Sequential Stimulator, KYPHON EXPRESS II KYPHOPAK TRAY, Belbuca, Intracept.
Industry payments across UT — which companies pay providers there.
